688016 心脉医疗
已收盘 03-28 15:00:00
资讯
新帖
简况
心脉医疗(688016)2023年业绩点评:23年业绩快速增长 研发投入持续强劲
光大证券股份有... · 19:43
心脉医疗(688016)2023年业绩点评:23年业绩快速增长 研发投入持续强劲
平安证券:给予心脉医疗增持评级
证券之星 · 18:17
平安证券:给予心脉医疗增持评级
心脉医疗(688016)2月29日股东户数1.01万户,较上期增加3.12%
证券之星 · 17:13
心脉医疗(688016)2月29日股东户数1.01万户,较上期增加3.12%
心脉医疗大幅上涨 发布2023年年度报告
智选洞察 · 10:00
心脉医疗大幅上涨 发布2023年年度报告
社保基金去年四季度持有科创板股名单(附股)
证券时报网 · 08:14
社保基金去年四季度持有科创板股名单(附股)
图解心脉医疗年报:第四季度单季净利润同比增85.74%
证券之星 · 01:36
图解心脉医疗年报:第四季度单季净利润同比增85.74%
心脉医疗2023年净利4.92亿同比增长37.98% 财务总监李春芳薪酬120.71万
挖贝网 · 03-27 22:26
心脉医疗2023年净利4.92亿同比增长37.98% 财务总监李春芳薪酬120.71万
心脉医疗:2023年度净利润约4.92亿元,同比增加37.98%
每日经济新闻 · 03-27 19:50
心脉医疗:2023年度净利润约4.92亿元,同比增加37.98%
注意!心脉医疗将于4月18日召开股东大会
每日经济新闻 · 03-27 19:46
注意!心脉医疗将于4月18日召开股东大会
心脉医疗将于4月18日召开股东大会,审议续聘会计师事务所等议案
金融界 · 03-27 19:44
心脉医疗将于4月18日召开股东大会,审议续聘会计师事务所等议案
心脉医疗:2023年净利同比增37.98% 拟10送4.9股派30元
证券时报网 · 03-27 19:36
心脉医疗:2023年净利同比增37.98% 拟10送4.9股派30元
人工智能+”行动出台,哪些板块有望受益?
银华基金 · 03-20
人工智能+”行动出台,哪些板块有望受益?
东方财富证券给予心脉医疗增持评级 动态点评:业绩稳健增长 产品竞争力持续提升
每日经济新闻 · 03-12
东方财富证券给予心脉医疗增持评级 动态点评:业绩稳健增长 产品竞争力持续提升
心脉医疗获融资买入0.12亿元,近三日累计买入0.28亿元
金融界 · 03-12
心脉医疗获融资买入0.12亿元,近三日累计买入0.28亿元
心脉医疗03月05日遭主力抛售747万元 环比增加179.78%
自选股智能写手 · 03-05
心脉医疗03月05日遭主力抛售747万元 环比增加179.78%
心脉医疗02月29日遭主力抛售1352万元 环比增加576.00%
自选股智能写手 · 02-29
心脉医疗02月29日遭主力抛售1352万元 环比增加576.00%
心脉医疗盘中大涨5.04% 主力净流入36万元
智选洞察 · 02-29
心脉医疗盘中大涨5.04% 主力净流入36万元
史上“最不对称”降息落地!小盘成长风格再迎流动性提振?
银华基金 · 02-28
史上“最不对称”降息落地!小盘成长风格再迎流动性提振?
心脉医疗获北向资金买入2010.66万元,累计持股69.36万股
金融界 · 02-27
心脉医疗获北向资金买入2010.66万元,累计持股69.36万股
惠泰、心脉医疗2023年业绩均高增 国产心血管器械厂商加速“抢滩”
21世纪经济报道 · 02-26
惠泰、心脉医疗2023年业绩均高增 国产心血管器械厂商加速“抢滩”
加载更多
公司概况
公司名称:
上海微创心脉医疗科技(集团)股份有限公司
所属行业:
专用设备制造业
上市日期:
2019-07-22
主营业务:
上海微创心脉医疗科技(集团)股份有限公司主要从事主动脉及外周血管介入医疗器械的研发、生产和销售。主要产品为胸主动脉覆膜支架系统、腹主动脉覆膜支架系统、术中支架类、球囊类、支架类。公司自成立以来,一直深耕于主动脉及外周血管介入医疗器械领域,通过多年的经验积累,公司已发展成我国主动脉血管介入医疗器械的龙头企业。公司产品已进入全国约1900家医院,主动脉产品国内市场占有率已连续多年排名国产品牌第一。
发行价格:
46.23
{"stockData":{"symbol":"688016","market":"SH","secType":"STK","nameCN":"心脉医疗","latestPrice":181.61,"timestamp":1711609200000,"preClose":174.55,"halted":0,"volume":1193284,"delay":0,"floatShares":71978100,"shares":82726299,"eps":7.5912,"marketStatus":"已收盘","marketStatusCode":5,"change":7.06,"latestTime":"03-28 15:00:00","open":176.3,"high":185.77,"low":176.21,"amount":218000000,"amplitude":0.0548,"askPrice":181.8,"askSize":2,"bidPrice":181.61,"bidSize":1,"shortable":0,"etf":0,"ttmEps":7.5912,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1711675800000},"adr":0,"adjPreClose":174.55,"symbolType":"stock_kcb","openAndCloseTimeList":[[1711589400000,1711596600000],[1711602000000,1711609200000]],"highLimit":192.01,"lowLimit":157.1,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":82726253,"pbRate":3.91,"roa":"--","roe":"26.43%","epsLYR":6.81,"committee":-0.346154,"marketValue":15024000000,"floatMarketCap":13072000000,"peRate":23.923754,"changeRate":0.0404,"turnoverRate":0.0166,"status":0,"afterMarket":{"amount":0,"volume":0,"close":181.61,"buyVolume":0,"sellVolume":0,"time":1711611238379,"indexStatus":"已收盘 03-28 15:30:00","preClose":174.55}},"requestUrl":"/m/hq/s/688016","defaultTab":"news","newsList":[{"id":"2422082162","title":"心脉医疗(688016)2023年业绩点评:23年业绩快速增长 研发投入持续强劲","url":"https://stock-news.laohu8.com/highlight/detail?id=2422082162","media":"光大证券股份有...","top":-1,"share":"https://www.laohu8.com/m/news/2422082162?lang=zh_cn&edition=full","pubTime":"2024-03-28 19:43","pubTimestamp":1711626215,"startTime":"0","endTime":"0","summary":"事件:公司发布23 年年报,2023 年全年实现收入11.87 亿元,归母净利润4.92 亿元,扣非归母净利润4.62 亿元。单季度来看,23 年Q4 单季度实现收入2.99 亿元,归母净利润1.04 亿元,业绩符合市场预期。分产品来看,公司主动脉支架收入9.40 亿元,术中支架收入1.32 亿元,外周及其他收入1.15 亿元。研发持续强劲,产品管线有望进一步丰富。2023 年公司各研发管线均取得重要进展,6 款产品向国家药监局递交注册资料。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281943428b6da39b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281943428b6da39b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422686211","title":"平安证券:给予心脉医疗增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2422686211","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2422686211?lang=zh_cn&edition=full","pubTime":"2024-03-28 18:17","pubTimestamp":1711621025,"startTime":"0","endTime":"0","summary":"平安证券股份有限公司叶寅,倪亦道近期对心脉医疗进行研究并发布了研究报告《2023高增长兑现,产品渗透与迭代保障增长持续性》,本报告对心脉医疗给出增持评级,当前股价为181.61元。海外毛利率因传统OEM产品收入占比进一步下降,毛利率同比增加5.95pct。维持“推荐”评级。最新盈利预测明细如下:该股最近90天内共有12家机构给出评级,买入评级9家,增持评级3家;过去90天内机构目标均价为213.9。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281818308b6d5ef4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281818308b6d5ef4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422515401","title":"心脉医疗(688016)2月29日股东户数1.01万户,较上期增加3.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422515401","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2422515401?lang=zh_cn&edition=full","pubTime":"2024-03-28 17:13","pubTimestamp":1711617210,"startTime":"0","endTime":"0","summary":"证券之星消息,近日心脉医疗披露,截至2024年2月29日公司股东户数为1.01万户,较12月31日增加306.0户,增幅为3.12%。在医疗器械行业个股中,心脉医疗股东户数低于行业平均水平,截至2月29日,医疗器械行业平均股东户数为2.18万户。心脉医疗近1年股东户数变动明细见下表:根据统计,心脉医疗2023年12月31日至2024年2月29日,主力资金净流出5767.19万元,游资资金净流入1.1亿元,散户资金净流出5260.26万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032817162587bffb75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032817162587bffb75&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422907002","title":"心脉医疗大幅上涨 发布2023年年度报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2422907002","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2422907002?lang=zh_cn&edition=full","pubTime":"2024-03-28 10:00","pubTimestamp":1711591249,"startTime":"0","endTime":"0","summary":"03月28日,心脉医疗股价大幅上涨,截至10点00分,心脉医疗上涨5.13%,报183.50元/股,成交9385万元,换手率0.72%,振幅4.18%。消息解读心脉医疗发布2023年年度报告,报告期内公司实现营业收入11.87亿元,同比增长32.43%;归属于上市公司股东的净利润4.92亿元,同比增长37.98%;归属于上市公司股东的扣除非经常性损益的净利润4.62亿元,同比增长42.74%;基本每股收益6.81元/股。现通报第五批医疗器械网络销售违法违规案件信息。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328105322791d6ab0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328105322791d6ab0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422974274","title":"社保基金去年四季度持有科创板股名单(附股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2422974274","media":"证券时报网","top":-1,"share":"https://www.laohu8.com/m/news/2422974274?lang=zh_cn&edition=full","pubTime":"2024-03-28 08:14","pubTimestamp":1711584840,"startTime":"0","endTime":"0","summary":"证券时报网讯,证券时报数据宝统计显示,社保基金最新出现在12只科创板股前十大流通股东名单中,合计持股量7450.04万股,期末持股市值合计38.42亿元。社保基金持有科创板股中,从前十大流通股东名单中社保基金家数来看,生益电子、奥特维、心脉医疗等3只股有2家社保基金集中现身,持股量分别为1565.61万股、497.44万股、330.34万股。社保基金持股市值居前的有柏楚电子、心脉医疗、联瑞新材,持股市值分别为8.74亿元、6.43亿元、4.72亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280826138b6b6a0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280826138b6b6a0f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422949269","title":"图解心脉医疗年报:第四季度单季净利润同比增85.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422949269","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2422949269?lang=zh_cn&edition=full","pubTime":"2024-03-28 01:36","pubTimestamp":1711560996,"startTime":"0","endTime":"0","summary":"证券之星消息,心脉医疗2023年年报显示,公司主营收入11.87亿元,同比上升32.43%;归母净利润4.92亿元,同比上升37.98%;扣非净利润4.62亿元,同比上升42.74%;其中2023年第四季度,公司单季度主营收入2.99亿元,同比上升28.63%;单季度归母净利润1.04亿元,同比上升85.74%;单季度扣非净利润9687.27万元,同比上升100.91%;负债率9.01%,投资收益914.85万元,财务费用-841.38万元,毛利率76.45%。财报数据概要请见下图:以上内容由证券之星根据公开信息整理,由算法生成,与本站立场无关。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280140288b6a7b18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403280140288b6a7b18&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422156539","title":"心脉医疗2023年净利4.92亿同比增长37.98% 财务总监李春芳薪酬120.71万","url":"https://stock-news.laohu8.com/highlight/detail?id=2422156539","media":"挖贝网","top":-1,"share":"https://www.laohu8.com/m/news/2422156539?lang=zh_cn&edition=full","pubTime":"2024-03-27 22:26","pubTimestamp":1711549601,"startTime":"0","endTime":"0","summary":"报告期内经营活动产生的现金流量净额为558,305,913.27元,归属于上市公司股东的净资产3,843,816,151.24元。报告期内公司实现营业收入1,187,204,459.56元,同比增长32.43%;归属于上市公司股东的净利润492,431,974.71元,同比增长37.98%。本报告期内营业收入、归属于上市公司股东的净利润增长均超30%,主要系报告期内公司主要产品受到市场广泛认可,产品竞争力持续增强,产销量稳步提升。公告显示,报告期内董事、监事、高级管理人员报酬合计1,594.02万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272230588b69ffe2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272230588b69ffe2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422995004","title":"心脉医疗:2023年度净利润约4.92亿元,同比增加37.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422995004","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2422995004?lang=zh_cn&edition=full","pubTime":"2024-03-27 19:50","pubTimestamp":1711540201,"startTime":"0","endTime":"0","summary":"每经AI快讯,心脉医疗 3月27日晚间发布年度业绩报告称,2023年营业收入约11.87亿元,同比增加32.43%;归属于上市公司股东的净利润约4.92亿元,同比增加37.98%;基本每股收益6.81元,同比增加37.3%。2022年1至12月份,心脉医疗的营业收入构成为:主动脉及外周血管用产品占比100.0%。心脉医疗的董事长是Jonathan Chen,男,49岁,学历背景为本科;总经理是朱清,男,43岁,学历背景为硕士。截至发稿,心脉医疗市值为144亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272019408b69a9b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272019408b69a9b1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422399573","title":"注意!心脉医疗将于4月18日召开股东大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2422399573","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2422399573?lang=zh_cn&edition=full","pubTime":"2024-03-27 19:46","pubTimestamp":1711539965,"startTime":"0","endTime":"0","summary":"心脉医疗3月27日发布公告称,2024年4月18日13点30分,公司将在上海市浦东新区康新公路3399弄25号楼9层公司会议室召开2023年年度股东大会。本次股东大会将审议《公司2023年年度报告及其摘要》等议案,2024年4月11日收市后登记在册的股东可现场参会投票,或通过交易所投票系统行使表决权。2022年1至12月份,心脉医疗的营业收入构成为:主动脉及外周血管用产品占比100.0%。截至发稿,心脉医疗市值为144亿元。心脉医疗将于4月18日召开股东大会","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032719591987bc3972&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032719591987bc3972&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422222960","title":"心脉医疗将于4月18日召开股东大会,审议续聘会计师事务所等议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2422222960","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2422222960?lang=zh_cn&edition=full","pubTime":"2024-03-27 19:44","pubTimestamp":1711539855,"startTime":"0","endTime":"0","summary":"金融界3月27日消息,心脉医疗发布公告,将于2024年4月18日召开年度股东大会,网络投票同日进行。股权登记日为4月11日,当日收市后持有心脉医疗股票的投资者可以参与投票。会议地点:上海市浦东新区康新公路3399弄25号楼9层公司会议室。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032719441787bc2f0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032719441787bc2f0d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422960736","title":"心脉医疗:2023年净利同比增37.98% 拟10送4.9股派30元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422960736","media":"证券时报网","top":-1,"share":"https://www.laohu8.com/m/news/2422960736?lang=zh_cn&edition=full","pubTime":"2024-03-27 19:36","pubTimestamp":1711539360,"startTime":"0","endTime":"0","summary":"证券时报e公司讯,心脉医疗(688016)3月27日晚间披露年报,2023年实现营业收入11.87亿元,同比增长32.43%;净利润4.92亿元,同比增长37.98%;基本每股收益6.81元。公司拟每10股送红股4.9股(含税)并派发现金红利30元(含税)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403271937148b698d0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403271937148b698d0b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420738673","title":"人工智能+”行动出台,哪些板块有望受益?","url":"https://stock-news.laohu8.com/highlight/detail?id=2420738673","media":"银华基金","top":-1,"share":"https://www.laohu8.com/m/news/2420738673?lang=zh_cn&edition=full","pubTime":"2024-03-20 07:30","pubTimestamp":1710891050,"startTime":"0","endTime":"0","summary":"“人工智能+”行动有望拉动算力全产业链发展,国产化进程有望加速。整体我国AI全产业链供需两端具有较为良好的基础,“人工智能+”行动顶层设计的出台,有望进一步推动产业链相关科技创新企业的成长斜率。在“人工智能+”行动加持科技创新赛道、市场开启技术性反弹的大背景下,高弹性、高锐度的科创100指数有望成为进攻性看多市场中“锋利的矛”!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403200715407a4dbe50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403200715407a4dbe50&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418845715","title":"东方财富证券给予心脉医疗增持评级 动态点评:业绩稳健增长 产品竞争力持续提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2418845715","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2418845715?lang=zh_cn&edition=full","pubTime":"2024-03-12 17:33","pubTimestamp":1710236016,"startTime":"0","endTime":"0","summary":"东方财富证券03月12日发布研报称,给予心脉医疗(688016.SH,最新价:187.55元)增持评级。评级理由主要包括:1)业务规模不断扩大,海外占比持续提升;2)研发实力强劲,在研管线进展顺利。风险提示:产品集中带量采购政策变化风险产品升级及新产品开发风险市场竞争加剧风险。AI点评:心脉医疗近一个月获得2份券商研报关注,买入2家。文章来源:每日经济新闻原标题:东方财富证券给予心脉医疗增持评级,动态点评:业绩稳健增长,产品竞争力持续提升","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031218192587766271&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031218192587766271&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418499013","title":"心脉医疗获融资买入0.12亿元,近三日累计买入0.28亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418499013","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2418499013?lang=zh_cn&edition=full","pubTime":"2024-03-12 08:14","pubTimestamp":1710202494,"startTime":"0","endTime":"0","summary":"3月11日,沪深两融数据显示,心脉医疗获融资买入额0.12亿元,居两市第707位,当日融资偿还额0.13亿元,净卖出93.17万元。最近三个交易日,7日-11日,心脉医疗分别获融资买入0.10亿元、0.07亿元、0.12亿元。融券方面,当日融券卖出0.42万股,净买入0.86万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031208170787741dbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031208170787741dbc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417457902","title":"心脉医疗03月05日遭主力抛售747万元 环比增加179.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417457902","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417457902?lang=zh_cn&edition=full","pubTime":"2024-03-05 15:19","pubTimestamp":1709623164,"startTime":"0","endTime":"0","summary":"03月05日, 心脉医疗股价跌1.26%,报收187.02元,成交金额1.14亿元,换手率0.85%,振幅2.24%,量比0.75。心脉医疗今日主力资金净流出747万元,连续5日净流出,上一交易日主力净流出267万元,今日环比增加179.78%。近一年数据显示,该股主力连续5日净流出后,次日下跌概率为50.00%,平均跌幅为1.70%。该股近5个交易日上涨1.67%,主力资金累计净流出3258万元;近20日主力资金累计净流出5779万元,其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030515421687525dfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030515421687525dfc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415593100","title":"心脉医疗02月29日遭主力抛售1352万元 环比增加576.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2415593100","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415593100?lang=zh_cn&edition=full","pubTime":"2024-02-29 15:19","pubTimestamp":1709191152,"startTime":"0","endTime":"0","summary":"02月29日, 心脉医疗股价涨6.47%,报收188.48元,成交金额2.30亿元,换手率1.73%,振幅7.67%,量比1.52。心脉医疗今日主力资金净流出1352万元,上一交易日主力净流出200万元,今日环比增加576.00%。该股近5个交易日上涨9.65%,主力资金累计净流出1725万元;近20日主力资金累计净流出2976万元,其中净流出天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402291529528aef464e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402291529528aef464e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415991585","title":"心脉医疗盘中大涨5.04% 主力净流入36万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415991585","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2415991585?lang=zh_cn&edition=full","pubTime":"2024-02-29 10:39","pubTimestamp":1709174396,"startTime":"0","endTime":"0","summary":"02月29日,心脉医疗股价大幅上涨,截至10点39分,心脉医疗上涨5.04%,报185.95元/股,成交7738万元,换手率0.59%,振幅6.03%。资金动向截止发稿,心脉医疗获得主力净流入36万元,其中超大单流入34万元,大单流入2万元。数据显示,该股今日净流入较近5日净流入均值增加169万元。北向资金方面,心脉医疗02月28日获得北向资金减持1.49万股,截至02月28日,北向资金当前共持有心脉医疗69.91万股,市值1.30亿元,持股占流通股比为0.97%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402291619317915dc02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402291619317915dc02&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414337401","title":"史上“最不对称”降息落地!小盘成长风格再迎流动性提振?","url":"https://stock-news.laohu8.com/highlight/detail?id=2414337401","media":"银华基金","top":-1,"share":"https://www.laohu8.com/m/news/2414337401?lang=zh_cn&edition=full","pubTime":"2024-02-28 07:45","pubTimestamp":1709077503,"startTime":"0","endTime":"0","summary":"导语:2月20日,史上“最不对称”降息落地,5年期以上LPR超预期、单边大幅度下调25BP指向企业中长期融资成本有望下行,叠加1月M2-M1剪刀差的收敛和信贷投放“开门红”,实体经济复苏动能或将持续增强。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240228074132791535ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240228074132791535ff&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414864183","title":"心脉医疗获北向资金买入2010.66万元,累计持股69.36万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2414864183","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2414864183?lang=zh_cn&edition=full","pubTime":"2024-02-27 07:34","pubTimestamp":1708990454,"startTime":"0","endTime":"0","summary":"2月27日,巨灵财经数据显示,北向资金26日增持心脉医疗预估2010.66万元,累计持股69.36万股,总计持有市值1.24亿元,占流通股比例0.96%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022707342487c43afa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022707342487c43afa&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414488328","title":"惠泰、心脉医疗2023年业绩均高增 国产心血管器械厂商加速“抢滩”","url":"https://stock-news.laohu8.com/highlight/detail?id=2414488328","media":"21世纪经济报道","top":-1,"share":"https://www.laohu8.com/m/news/2414488328?lang=zh_cn&edition=full","pubTime":"2024-02-26 20:00","pubTimestamp":1708948800,"startTime":"0","endTime":"0","summary":"2月23日晚间,国内两大心血管器械“新秀”惠泰医疗、心脉医疗同时发布了2023年业绩快报,均实现业绩高速增长。在公告发布后的首个交易日,惠泰医疗、心脉医疗股价分别上涨2.69%、2.99%。两大“新秀”业绩均高增一直以来,心血管医疗器械市场由于技术壁垒高、起步发展晚,国产化率和渗透率较低。其中,惠泰医疗2023年实现营业收入16.51亿元,较上年同期增长35.79%;归属于母公司所有者的净利润5.36亿元,较上年同期增长49.61%,位居业绩预告的中值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402262002157914a8df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402262002157914a8df&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2019-07-22","address":"上海市浦东新区康新公路3399弄1号","stockEarnings":[{"period":"1week","weight":-0.0425},{"period":"1month","weight":-0.0208},{"period":"3month","weight":-0.0891},{"period":"6month","weight":-0.0584},{"period":"1year","weight":0.0324},{"period":"ytd","weight":-0.1032}],"companyName":"上海微创心脉医疗科技(集团)股份有限公司","boardCode":"AI0035","perCapita":"7112股","boardName":"专用设备制造业","registeredCapital":"8272万元","compareEarnings":[{"period":"1week","weight":-0.0281},{"period":"1month","weight":0.0054},{"period":"3month","weight":0.013},{"period":"6month","weight":-0.0377},{"period":"1year","weight":-0.0777},{"period":"ytd","weight":0.0061}],"survey":" 上海微创心脉医疗科技(集团)股份有限公司主要从事主动脉及外周血管介入医疗器械的研发、生产和销售。主要产品为胸主动脉覆膜支架系统、腹主动脉覆膜支架系统、术中支架类、球囊类、支架类。公司自成立以来,一直深耕于主动脉及外周血管介入医疗器械领域,通过多年的经验积累,公司已发展成我国主动脉血管介入医疗器械的龙头企业。公司产品已进入全国约1900家医院,主动脉产品国内市场占有率已连续多年排名国产品牌第一。","serverTime":1711638350920,"listedPrice":46.23,"stockholders":"10120人(较上一季度增加3.12%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.3","shortVersion":"4.22.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"心脉医疗(688016)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供心脉医疗(688016)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"心脉医疗,688016,心脉医疗股票,心脉医疗股票老虎,心脉医疗股票老虎国际,心脉医疗行情,心脉医疗股票行情,心脉医疗股价,心脉医疗股市,心脉医疗股票价格,心脉医疗股票交易,心脉医疗股票购买,心脉医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"心脉医疗(688016)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供心脉医疗(688016)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}